Shinichi Imafuku (Shinich Imafuku, S Imafuku)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 78

Top Venues

The Journal of dermatology

Experimental dermatology

The Journal of dermatological treatment

Dermatologic therapy

Fukuoka University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fukuoka University

Japan

Professor :: Dermatology

Publications

Neil J Korman, Richard Bruce Warren, Jerry Bagel, April W Armstrong, Melinda J Gooderham, Bruce E Strober, Diamant Thaҫi, Akimichi Morita, Shinichi Imafuku, Peter Foley, Howard Sofen, Min Zheng, Lauren Hippeli, Renata M Kisa, Subhashis Banerjee, Andrew Blauvelt
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials. The Journal of dermatological treatment 35 (1) (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology (2024)
Yayoi Tada, Ahmed M Soliman, Kanako Ishii, Ryuta Sakuma, Andreas Pinter, Matthew Davis, Dominic Nunag, Marric Buessing, Luis Puig, Shinichi Imafuku
Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in Japan. Experimental dermatology 33 (5) (2024)
Akimichi Morita, Yukari Okubo, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, A E J Gibson, Frauke Becker, Nataliya Bogoeva, Mamitaro Ohtsuki
Expert consensus on systemic therapy for plaque psoriasis with limited skin involvement in JAPAN: Results from a DELPHI study. The Journal of dermatology (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology 51 (3) (2024)
Yayoi Tada, Ahmed M Soliman, Kanako Ishii, Ryuta Sakuma, Andreas Pinter, Matthew Davis, Dominic Nunag, Marric Buessing, Luis Puig, Shinichi Imafuku
Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in Japan. Experimental dermatology 33 (5) (2024)
Shinichi Imafuku, Satoshi Takeuchi, Kazunori Urabe, Masataka Arakawa, Ryo Sasaki, Daigo Oka, Takenobu Yamamoto, Fumitake Ono, Shigeho Shirahama, Shinichiro Yasumoto, Hiroaki Fukuda
An exploratory study of the efficacy and safety of amenamevir for the treatment of herpes zoster in patients receiving immunosuppressive drugs. The Journal of dermatology (2024)
Yuko Higashi, Shinichi Imafuku, Noriko Tsuruta, Kenta Murotani, null null
Systemic therapy for psoriasis and the risk of cutaneous infections. The Journal of dermatology 51 (7) (2024)
Ryosuke Masuyuki, Emi Sato, Shinichi Imafuku
A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody. The Journal of dermatology (2024)
Ryosuke Masuyuki, Emi Sato, Shinichi Imafuku
A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody. The Journal of dermatology 51 (9) (2024)
Mamitaro Ohtsuki, Yukari Okubo, Hidehisa Saeki, Atsuyuki Igarashi, Shinichi Imafuku, Masatoshi Abe, Siddharth Chaudhari, Masafumi Yaguchi, Ayumi Emoto, Akimichi Morita
Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance study. The Journal of dermatology (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology 51 (3) (2024)
Chika Ohata, Hisataka Anezaki, Tetsuji Yanase, Eri Katayama, Sakae Kaneko, Kanami Saito, Mariko Yamane, Sei Nakamaru, Noriko Tsuruta, Fusako Okazaki, Kotaro Ito, Satoko Kikuchi, Yuta Koike, Takuya Miyagi, Kazunari Sugita, Takeshi Nakahara, Daiki Takezaki, Hiroshi Saruwatari, Yuichi Yoshida, Kentaro Yonekura, Yuko Higashi, Yu Sawada, Yuko Chinuki, Kazuki Yamaguchi, Shinichi Imafuku
Real-world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational study. The Journal of dermatology (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology (2024)
Mamitaro Ohtsuki, Yukari Okubo, Hidehisa Saeki, Atsuyuki Igarashi, Shinichi Imafuku, Masatoshi Abe, Siddharth Chaudhari, Masafumi Yaguchi, Ayumi Emoto, Akimichi Morita
Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance study. The Journal of dermatology 51 (7) (2024)
Yuko Higashi, Shinichi Imafuku, Noriko Tsuruta, Kenta Murotani, null null
Systemic therapy for psoriasis and the risk of cutaneous infections. The Journal of dermatology (2024)
Neil J Korman, Richard Bruce Warren, Jerry Bagel, April W Armstrong, Melinda J Gooderham, Bruce E Strober, Diamant Thaҫi, Akimichi Morita, Shinichi Imafuku, Peter Foley, Howard Sofen, Min Zheng, Lauren Hippeli, Renata M Kisa, Subhashis Banerjee, Andrew Blauvelt
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials. The Journal of dermatological treatment 35 (1) (2024)
Shinichi Imafuku, Kenta Korematsu, Naoko Mori, Tsuyoshi Kani, Keita Matsui
Real-world safety and efficacy of amenamevir in patients with herpes zoster in Japan: A postmarketing observational study (REWARD). The Journal of dermatology (2023)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Kenzo Takahashi, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis. The Journal of dermatology 50 (5) (2023)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Kenzo Takahashi, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis. The Journal of dermatology 50 (5) (2023)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Kenzo Takahashi, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis. The Journal of dermatology 50 (5) (2023)
Yayoi Tada, Akimichi Morita, Keiichi Yamanaka, Michihiro Kono, Shinichi Imafuku, Yukari Okubo, Fumikazu Yamazaki, Taisuke Kawamura, Asako Itakura, Mamitaro Ohtsuki
Real-world retention rates and effectiveness of secukinumab in psoriasis: Results from a multicenter cohort study (RAILWAY). The Journal of dermatology (2023)
Tetsuji Yanase, Noriko Tsuruta, Kazuki Yamaguchi, Chika Ohata, Bungo Ohyama, Eri Katayama, Kazunari Sugita, Maki Kuwashiro, Aki Hashimoto, Kentaro Yonekura, Yuko Higashi, Hiroyuki Murota, Yuta Koike, Yuki Matsuzaka, Satoko Kikuchi, Yutaka Hatano, Kanami Saito, Kenzo Takahashi, Takuya Miyagi, Sakae Kaneko, Masataka Ota, Kayo Harada, Shin Morizane, Kenta Ikeda, Masutaka Furue, Takeshi Nakahara, Fusako Okazaki, Natsuko Sasaki-Saito, Etsuko Okada, Yuichi Yoshida, Kotaro Ito, Shinichi Imafuku
Survival rates of systemic interventions for psoriasis in the Western Japan Psoriasis Registry: A multicenter retrospective study. The Journal of dermatology (2023)
Shinichi Imafuku
Recent advance in management of herpes simplex in Japan. The Journal of dermatology (2023)
Shiori Katayama, Kaori Koga, Masakazu Fujimoto, Ibu Matsuzaki, Kazuki Nabeshima, Shinichi Imafuku, Makoto Hamasaki
Expression of laminin332 γ2 at the invasive front is associated with tumor budding and poor prognosis in cutaneous squamous cell carcinoma. The Journal of dermatology (2023)
Chika Ohata, Hisataka Anezaki, Sakae Kaneko, Fusako Okazaki, Kotaro Ito, Yuki Matsuzaka, Satoko Kikuchi, Yuta Koike, Hiroyuki Murota, Takuya Miyagi, Kenzo Takahashi, Kazunari Sugita, Aki Hashimoto, Takeshi Nakahara, Shin Morizane, Bungo Ohyama, Hiroshi Saruwatari, Tetsuji Yanase, Yuichi Yoshida, Kentaro Yonekura, Yuko Higashi, Yutaka Hatano, Kanami Saito, Eri Katayama, Mariko Yamane, Fumikazu Yamazaki, Noriko Tsuruta, Shinichi Imafuku
Clinical characteristics of patients with psoriasis with family history: A multicenter observational study. The Journal of dermatology (2023)
Shinichi Imafuku
Recent advance in management of herpes simplex in Japan. The Journal of dermatology 50 (3) (2023)
Shinichi Imafuku, Yayoi Tada, Lauren Hippeli, Subhashis Banerjee, Akimichi Morita, Mamitaro Ohtsuki
Efficacy and safety of the selective TYK2 inhibitor, deucravacitinib, in Japanese patients with moderate to severe plaque psoriasis: Subgroup analysis of a randomized, double-blind, placebo-controlled, global phase 3 trial. The Journal of dermatology (2023)
Shinichi Imafuku
Recent advance in management of herpes simplex in Japan. The Journal of dermatology 50 (3) (2023)
Hidehisa Saeki, Masashi Akiyama, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukihiro Ohya, Norito Katoh, Hideto Kameda, Kenji Kabashima, Yuichiro Tsunemi, Michihiro Hide, Mamitaro Ohtsuki, null null
English version of Japanese guidance for biologics in treating atopic dermatitis. The Journal of dermatology (2023)
Shinichi Imafuku
Recent advance in management of herpes simplex in Japan. The Journal of dermatology 50 (3) (2023)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Shigetoshi Sano, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). The Journal of dermatology 50 (2) (2022)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Shigetoshi Sano, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). The Journal of dermatology 50 (2) (2022)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Shigetoshi Sano, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). The Journal of dermatology 50 (2) (2022)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Shigetoshi Sano, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). The Journal of dermatology (2022)
Akimichi Morita, Tsen Fang Tsai, Evelyn Yap Wen Yee, Yukari Okubo, Shinichi Imafuku, Min Zheng, Ling Li, Manuel Quaresma, Christian Thoma, Siew Eng Choon
Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil™ 1 study. The Journal of dermatology (2022)
Hidehisa Saeki, Yasumasa Kanai, Kenta Murotani, Kei Ito, Takuya Miyagi, Hidetoshi Takahashi, Yayoi Tada, Mari Higashiyama, Yuki Hashimoto, Hiroki Kitabayashi, Shinichi Imafuku
Work productivity in real-life employed patients with plaque psoriasis: Results from the ProLOGUE study. The Journal of dermatology 49 (10) (2022)
Kanae Nakamura, Emi Sato, Shinichi Imafuku
A case of erythema nodosum concomitant with ulcerative colitis relieved by tofacitinib. Dermatologic therapy (2022)
Yoko Mizutani, Yasumasa Kanai, Kenta Murotani, Masaru Honma, Mari Higashiyama, Satomi Kobayashi, Takanobu Nomura, Mariko Seishima, Shinichi Imafuku
Treatment with brodalumab is not associated with improved sleep problems in real-life patients with plaque psoriasis: Results of the ProLOGUE study. The Journal of dermatology (2022)
Masaru Honma, Yasumasa Kanai, Kenta Murotani, Kei Ito, Chika Ohata, Fumikazu Yamazaki, Hidehisa Saeki, Mariko Seishima, Yoko Mizutani, Hiroki Kitabayashi, Shinichi Imafuku
Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The ProLOGUE study. The Journal of dermatology (2022)
Sayaka Takano-Kawasaki, Emi Sato, Kazuki Yamaguchi, Shinichi Imafuku
Trends in prescriptions of oral medications for psoriasis: A single-center retrospective study. The Journal of dermatology (2022)
Hidehisa Saeki, Masashi Akiyama, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukihiro Ohya, Norito Katoh, Hideto Kameda, Kenji Kabashima, Yuichiro Tsunemi, Michihiro Hide, Mamitaro Ohtsuki, null null
English version of Japanese guidance for the use of oral Janus kinase (JAK) inhibitors in the treatments of atopic dermatitis. The Journal of dermatology (2022)
Yuichi Yoshida, Yuko Ehara, Monji Koga, Shinichi Imafuku
Health-related quality of life in patients with neurofibromatosis 1 in Japan: A questionnaire survey using EQ-5D-5L. The Journal of dermatology 49 (12) (2022)
Andreas Wollenberg, Lisa A Beck, Marjolein de Bruin-Weller, Eric L Simpson, Shinichi Imafuku, M Boguniewicz, R Zachariae, C K Olsen, Jacob Pontoppidan Thyssen
Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials. The British journal of dermatology (2021)
Noriko Tsuruta, Shinichi Imafuku, null null
Establishment of the Western Japan Psoriasis Registry and first cross-sectional analysis of registered patients. The Journal of dermatology 48 (11) (2021)
Motoko Miyachi, Tomomi Imamura-Ichigatani, Honoka Ihara, Yasunori Ohga, Miku Nishimura, Emi Sato, Shogo Hoashi, Shinichi Imafuku
Herpes simplex virus DNA testing by a loop-mediated isothermal amplification method for accurate clinical diagnosis and detection of mucosal viral shedding. The Journal of dermatology (2021)
Atsuyuki Igarashi, Hidemi Nakagawa, Akimichi Morita, Yukari Okubo, Shigetoshi Sano, Shinichi Imafuku, Yayoi Tada, Masaru Honma, Alan M Mendelsohn, Masaki Kawamura, Mamitaro Ohtsuki
Efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 64-week phase 3 study (reSURFACE 1). The Journal of dermatology 48 (6) (2021)
Honami Nishio-Tatemichi, Emi Sato, Yoshitsugu Shibayama, Kaori Koga, Shinichi Imafuku
Sudden colour enhancement of congenital speckled lentiginous naevus after partial resection. The Australasian journal of dermatology 62 (2) (2021)
Chika Ohata, Noriko Tsuruta, Kentaro Yonekura, Yuko Higashi, Kanami Saito, Eri Katayama, Shinichi Imafuku, null null
Clinical characteristics of Japanese pustular psoriasis: A multicenter observational study. The Journal of dermatology (2021)
Yukari Okubo, Mamitaro Ohtsuki, Mayumi Komine, Shinichi Imafuku, Nastya Kassir, Rosemary Petric, Osamu Nemoto
Population pharmacokinetic and exposure-response analysis of apremilast in Japanese subjects with moderate to severe psoriasis. The Journal of dermatology 48 (11) (2021)
Shinichi Imafuku, Hidemi Nakagawa, Atsuyuki Igarashi, Akimichi Morita, Yukari Okubo, Shigetoshi Sano, Yayoi Tada, Osamu Nemoto, Stephen J Rozzo, Masaki Kawamura, Mamitaro Ohtsuki
Long-term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5-year extension of a phase 3 study (reSURFACE 1). The Journal of dermatology 48 (6) (2021)
Shinichi Imafuku, Akira Maeyama
Remission of anti-tumor necrosis factor-α antibody-induced palmoplantar pustulosis with the Janus kinase inhibitor baricitinib in a patient with rheumatoid arthritis. The Journal of dermatology 48 (5) (2021)
Emi Sato, Narumi Yano, Yuka Fujita, Shinichi Imafuku
Interleukin-17A suppresses granular layer formation in a 3-D human epidermis model through regulation of terminal differentiation genes. The Journal of dermatology 47 (4) (2020)
Shinichi Imafuku, Osamu Nemoto, Yukari Okubo, Mayumi Komine, Peter Schafer, Rosemary Petric, Mamitaro Ohtsuki
Pharmacodynamic analysis of apremilast in Japanese patients with moderate to severe psoriasis: Results from a phase 2b randomized trial. The Journal of dermatology 48 (1) (2020)
Shinichi Imafuku, Giulia Dormal, Yasushi Goto, Céline Jégou, Dominique Rosillon, Taizo Matsuki
Risk of herpes zoster in the Japanese population with immunocompromising and chronic disease conditions: Results from a claims database cohort study, from 2005 to 2014. The Journal of dermatology 47 (3) (2020)
Akie Kajita, Emi Sato, Shinichi Imafuku
Hypersensitivity due to unfractionated heparin treatment in a pregnant woman. The Journal of dermatology 47 (11) (2020)
Hidehisa Saeki, Tadashi Terui, Akimichi Morita, Shigetoshi Sano, Shinichi Imafuku, Akihiko Asahina, Mayumi Komine, Takafumi Etoh, Atsuyuki Igarashi, Hideshi Torii, Masatoshi Abe, Hidemi Nakagawa, Akira Watanabe, Hiroshi Yotsuyanagi, Mamitaro Ohtsuki, null null
Japanese guidance for use of biologics for psoriasis (the 2019 version). The Journal of dermatology 47 (3) (2020)
Bolortuya Bayaraa, Hisatomi Arima, Shinichi Imafuku
Body mass index in psoriatic patients with or without familial psoriasis. The Journal of dermatology 47 (4) (2020)
Bolortuya Bayaraa, Shinichi Imafuku
Sustainability and switching of biologics for psoriasis and psoriatic arthritis at Fukuoka University Psoriasis Registry. The Journal of dermatology 46 (5) (2019)
Sakae Kaneko, Noriko Tsuruta, Kazuki Yamaguchi, Takuya Miyagi, Kenzo Takahashi, Yuko Higashi, Shin Morizane, Hayato Nomura, Michiya Yamaguchi, Ryosuke Hino, Yu Sawada, Motonobu Nakamura, Bungo Ohyama, Chika Ohata, Kentaro Yonekura, Hiroaki Hayashi, Tetsuji Yanase, Yuki Matsuzaka, Kazunari Sugita, Satoko Kikuchi, Chikage Mitoma, Takeshi Nakahara, Masutaka Furue, Fusako Okazaki, Yuta Koike, Shinichi Imafuku, null null
Mycobacterium tuberculosis infection in psoriatic patients treated with biologics: Real-world data from 18 Japanese facilities. The Journal of dermatology 47 (2) (2019)
Noriko Tsuruta, Yutaka Narisawa, Shinichi Imafuku, Kotaro Ito, Kazuki Yamaguchi, Takuya Miyagi, Kenzo Takahashi, Hiroko Fukamatsu, Shin Morizane, Hideki Koketsu, Michiya Yamaguchi, Ryosuke Hino, Motonobu Nakamura, Bungo Ohyama, Chika Ohata, Maki Kuwashiro, Toshihiro Sato, Kanami Saito, Sakae Kaneko, Kentaro Yonekura, Hiroaki Hayashi, Tetsuji Yanase, Kenichi Morimoto, Kazunari Sugita, Shigeto Yanagihara, Satoko Kikuchi, Chikage Mitoma, Takeshi Nakahara, Masutaka Furue, Fusako Okazaki
Cross-sectional multicenter observational study of psoriatic arthritis in Japanese patients: Relationship between skin and joint symptoms and results of treatment with tumor necrosis factor-α inhibitors. The Journal of dermatology 46 (3) (2019)
Saori Masaki, Bolortuya Bayaraa, Shinichi Imafuku
Prevalence of inflammatory bowel disease in Japanese psoriatic patients. The Journal of dermatology 46 (7) (2019)
Yuka Kunimi, Shinichi Imafuku
Cholinergic urticaria with hypohidrosis successfully treated with omalizumab. The Journal of dermatology 47 (2) (2019)
Yuko Ehara, Monji Koga, Shinichi Imafuku, Osamu Yamamoto, Yuichi Yoshida
Distribution of diffuse plexiform neurofibroma on the body surface in patients with neurofibromatosis 1. The Journal of dermatology 47 (2) (2019)
Kotaro Ito, Bolortuya Bayaraa, Shinichi Imafuku
Relationship between the efficacy of biologics and clinical plaque psoriasis subtypes in Japanese patients: A single-center pilot study. The Journal of dermatology 46 (12) (2019)
Yuki Tsutsui, Monji Koga, Kaori Koga, Shinichi Imafuku
Child case of linear variant of telangiectasia macularis eruptiva perstans. The Journal of dermatology 46 (12) (2019)
Akimichi Morita, Hidetoshi Takahashi, Kentaro Ozawa, Shinichi Imafuku, Takekuni Nakama, Kenzo Takahashi, Takashi Matsuyama, Yukari Okubo, Susumu Kitamura, Naoto Matsuda, Yiwei Zhao, Masayuki Yokoyama, Nobukazu Hayashi, Tadashi Terui
Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa. The Journal of dermatology 46 (9) (2019)
Kotaro Ito, Saori Masaki, Manabu Hamada, Tetsuo Tokunaga, Hisashi Kokuba, Kenji Tashiro, Ichiro Yano, Shinichiro Yasumoto, Shinichi Imafuku
Efficacy and Safety of the Traditional Japanese Medicine Keigairengyoto in the Treatment of Acne Vulgaris. Dermatology research and practice 2018 (2018)
Yuka Kunimi, Monji Koga, Takuya Ishibashi, Yoshitsugu Tanaka, Takuaki Yamamoto, Shinichi Imafuku
Case of psoriatic arthritis mutilans whose finger dysfunction was successfully ameliorated by surgical intervention during infliximab treatment. The Journal of dermatology 45 (3) (2018)
Bolortuya Bayaraa, Shinichi Imafuku
Relationship between environmental factors, age of onset and familial history in Japanese patients with psoriasis. The Journal of dermatology 45 (6) (2018)
Susumu Ichiyama, Michiko Ito, Yoko Funasaka, Masatoshi Abe, Emi Nishida, Shinnosuke Muramatsu, Haruna Nishihara, Hiroshi Kato, Akimichi Morita, Shinichi Imafuku, Hidehisa Saeki
Assessment of medication adherence and treatment satisfaction in Japanese patients with psoriasis of various severities. The Journal of dermatology 45 (6) (2018)
Shinichi Imafuku, Min Zheng, Yayoi Tada, Xibao Zhang, Colin Theng, Suganthi Thevarajah, Yi Zhao, Hae Jun Song
Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy. The Journal of dermatology 45 (7) (2018)
R Naito, K Koga, M Masaki, N Fujii, K Ito, M Koga, Shinichi Imafuku
Multiple verrucous lesions of the feet in Waldenström macroglobulinaemia. Clinical and experimental dermatology 43 (1) (2017)
Honoka Ihara, Motoko Miyachi, Shinichi Imafuku
Relationship between serum anti-varicella zoster virus antibody titer and time from onset of herpes zoster. The Journal of dermatology 45 (2) (2017)
Shinichi Imafuku, Hitoe Torisu-Itakura, Atsushi Nishikawa, Fangyi Zhao, Gregory S Cameron, null null
Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1). The Journal of dermatology 44 (11) (2017)
Makoto Kawashima, Osamu Nemoto, Mariko Honda, Daisuke Watanabe, Juichiro Nakayama, Shinichi Imafuku, Toshiyuki Kato, Tsuneo Katsuramaki, null null
Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study. The Journal of dermatology 44 (11) (2017)
Mamitaro Ohtsuki, Akimichi Morita, Atsuyuki Igarashi, Shinichi Imafuku, Yayoi Tada, Hiroyuki Fujita, Ayako Fujishige, Masako Yamaguchi, Rie Teshima, Yumiko Tani, Hidemi Nakagawa
Secukinumab improves psoriasis symptoms in patients with inadequate response to cyclosporine A: A prospective study to evaluate direct switch. The Journal of dermatology 44 (10) (2017)

Shinichi Imafuku.css-eqlu8i{font-size:small;padding-left:4px;} (Shinich Imafuku, S Imafuku)

Publication Activity (10 Years)

Top Topics

Top Venues

Shinichi Imafuku (Shinich Imafuku, S Imafuku)